Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

RWD Curtain Lifted On US Cannabinoids Information Gap, But Lawful Use Remains TBD

Jan 08 2021

• By Malcolm Spicer

• Source: US Food and Drug Administration

Related Content

$2m For CBD Policy In FDA Budget, But No Directive On Setting Safe Level

Dec 19 2019

CBD Market Provides ‘Enormous Incentive’ For FDA's Regulatory Answer But Decision Remains TBD

Dec 10 2020

US Bill For CBD Supplement Path Draws Mixed Industry Response

Sep 12 2020

Cultivating Cannabinoid Safety Data In US: Principles, Projects And Problems

Jan 08 2021

Additional Topics

United States US States Cannabidiol CBD FDA Research & Development Advertising, Marketing & Sales Business Strategies Commercial Compliance Cosmetics Dietary Supplements Enforcement Ingredients Legislation Manufacturing OTC Drugs Policy Regulation Safety Consumer

More from Cannabis/CBD

More from Ingredients & Safety

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window